{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T03:09:32Z","timestamp":1774494572944,"version":"3.50.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T00:00:00Z","timestamp":1656288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T00:00:00Z","timestamp":1656288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Gerontol Geriat"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s00391-022-02080-0","type":"journal-article","created":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T09:03:11Z","timestamp":1656320591000},"page":"418-420","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Kognitive Trainingsma\u00dfnahmen f\u00fcr Demenz und leichte kognitive Beeintr\u00e4chtigung bei Parkinson-Erkrankung","Cognitive training interventions for dementia and mild cognitive impairment in Parkinson\u2019s disease"],"prefix":"10.1007","volume":"55","author":[{"given":"Thomas D.","family":"Kocar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Leinert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Kohler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"Meerpohl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Denkinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,27]]},"reference":[{"issue":"10","key":"2080_CR1","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.euroneuro.2011.08.008","volume":"21","author":"A Gustavsson","year":"2011","unstructured":"Gustavsson\u00a0A, Svensson\u00a0M, Jacobi\u00a0F, Allgulander\u00a0C, Alonso\u00a0J, Beghi\u00a0E, Dodel\u00a0R, Ekman\u00a0M, Faravelli\u00a0C, Fratiglioni\u00a0L, Gannon\u00a0B (2011) Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 21(10):718\u2013779","journal-title":"Eur Neuropsychopharmacol"},{"issue":"13","key":"2080_CR2","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1212\/01.wnl.0000306632.43729.24","volume":"70","author":"TC Buter","year":"2008","unstructured":"Buter\u00a0TC, Van Den Hout\u00a0A, Matthews\u00a0FE, Larsen\u00a0JP, Brayne\u00a0C, Aarsland\u00a0D (2008) Dementia and survival in Parkinson disease: a\u00a012-year population study. Neurology 70(13):1017\u20131022","journal-title":"Neurology"},{"issue":"6","key":"2080_CR3","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/mds.21956","volume":"23","author":"MA Hely","year":"2008","unstructured":"Hely\u00a0MA, Reid\u00a0WG, Adena\u00a0MA, Halliday\u00a0GM, Morris\u00a0JG (2008) The Sydney multicenter study of Parkinson\u2019s disease: the inevitability of dementia at 20\u00a0years. Mov Disord 23(6):837\u2013844","journal-title":"Mov Disord"},{"key":"2080_CR4","unstructured":"IQWiG (2009) Nichtmedikament\u00f6se Behandlung der Alzheimer Demenz"},{"key":"2080_CR5","unstructured":"Deuschl G, Oertel W, Reichmann H (2016) S3-Leitlinie Idiopathisches Parkinson-Syndrom. Deutsche Gesellschaft f\u00fcr Neurologie, Hrsg. Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie. https:\/\/www.dgn.org\/leitlinien. Zugegriffen: 9. Mai 2022"},{"key":"2080_CR6","unstructured":"Deuschl G, Maier W, Jessen F, Spottke A (2016) S3-Leitlinie Demenzen. 2016. Deutsche Gesellschaft f\u00fcr Neurologie, Hrsg. Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie. https:\/\/www.dgn.org\/leitlinien. Zugegriffen: 9. Mai 2022"},{"key":"2080_CR7","first-page":"CD012277","volume":"2","author":"NJ Gates","year":"2020","unstructured":"Gates\u00a0NJ, Rutjes\u00a0AW, Di Nisio\u00a0M, Karim\u00a0S, Chong\u00a0LY, March\u00a0E et\u00a0al (2020) Computerised cognitive training for 12 or more weeks for maintaining cognitive function in cognitively healthy people in late life. Cochrane Database Syst Rev 2:CD12277","journal-title":"Cochrane Database Syst Rev"},{"key":"2080_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.705407","author":"G Pagano","year":"2021","unstructured":"Pagano G, Boess FG, Taylor KI, Ricci B, Mollenhauer B, Poewe W, Boulay A, Anzures-Cabrera J, Vogt A, Marchesi M, Post A (2021) A phase II study to evaluate the safety and efficacy of prasinezumab in early Parkinson\u2019s disease (PASADENA): rationale, design, and baseline data. Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2021.705407","journal-title":"Front Neurol"},{"key":"2080_CR9","doi-asserted-by":"publisher","first-page":"852003","DOI":"10.3389\/fneur.2022.852003","volume":"13","author":"S Menon","year":"2022","unstructured":"Menon\u00a0S, Armstrong\u00a0S, Hamzeh\u00a0A, Visanji\u00a0NP, Sardi\u00a0SP, Tandon\u00a0A (2022) Alpha-synuclein targeting therapeutics for parkinson\u2019s disease and related synucleinopathies. Front Neurol 13:852003","journal-title":"Front Neurol"},{"issue":"13","key":"2080_CR10","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1056\/NEJMoa0809335","volume":"361","author":"CW Olanow","year":"2009","unstructured":"Olanow\u00a0CW, Rascol\u00a0O, Hauser\u00a0R, Feigin\u00a0PD, Jankovic\u00a0J, Lang\u00a0A, Langston\u00a0W, Melamed\u00a0E, Poewe\u00a0W, Stocchi\u00a0F, Tolosa\u00a0E (2009) A double-blind, delayed-start trial of rasagiline in Parkinson\u2019s disease. N\u00a0Engl J Med 361(13):1268\u20131278","journal-title":"N Engl J Med"},{"issue":"14","key":"2080_CR11","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1212\/WNL.0b013e3181d7d8e2","volume":"74","author":"JE Ahlskog","year":"2010","unstructured":"Ahlskog\u00a0JE, Uitti\u00a0RJ (2010) Rasagiline, Parkinson neuroprotection, and delayed-start trials: still no satisfaction? Neurology 74(14):1143\u20131148","journal-title":"Neurology"},{"key":"2080_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006504.pub2","author":"M Rolinski","year":"2012","unstructured":"Rolinski M, Fox C, Maidment I, McShane R (2012) Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson\u2019s disease dementia and cognitive impairment in Parkinson\u2019s disease. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD006504.pub2","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Zeitschrift f\u00fcr Gerontologie und Geriatrie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00391-022-02080-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00391-022-02080-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00391-022-02080-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T14:14:46Z","timestamp":1659968086000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00391-022-02080-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,27]]},"references-count":12,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["2080"],"URL":"https:\/\/doi.org\/10.1007\/s00391-022-02080-0","relation":{},"ISSN":["0948-6704","1435-1269"],"issn-type":[{"value":"0948-6704","type":"print"},{"value":"1435-1269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,27]]},"assertion":[{"value":"10 June 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"T.D.\u00a0Kocar, C.\u00a0Leinert, K.\u00a0Kohler, J.\u00a0Meerpohl und M.\u00a0Denkinger geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}